Detalhe da pesquisa
1.
Cell-programmed nutrient partitioning in the tumour microenvironment.
Nature
; 593(7858): 282-288, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33828302
2.
PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR.
Breast Cancer Res
; 26(1): 34, 2024 02 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38409028
3.
Targeting Histone Modifications in Bone and Lung Metastatic Cancers.
Curr Osteoporos Rep
; 19(3): 230-246, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33721181
4.
Dormancy in the Tumor Microenvironment.
Adv Exp Med Biol
; 1329: 35-49, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34664232
5.
Breast Cancer Dormancy in Bone.
Curr Osteoporos Rep
; 17(5): 353-361, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31468498
6.
Hallmarks of Bone Metastasis.
Calcif Tissue Int
; 102(2): 141-151, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29138883
7.
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
J Biol Chem
; 291(41): 21703-21716, 2016 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27539849
8.
Hypoxia and Bone Metastatic Disease.
Curr Osteoporos Rep
; 15(4): 231-238, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28597139
9.
Epigenetic control of the vicious cycle.
J Bone Oncol
; 44: 100524, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38304486
10.
Re-Evaluating the Role of PTHrP in Breast Cancer.
Cancers (Basel)
; 15(10)2023 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37345007
11.
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms.
J Bone Oncol
; 43: 100505, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37842554
12.
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy.
JBMR Plus
; 7(3): e10694, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36936362
13.
Leukemia inhibitory factor: a paracrine mediator of bone metabolism.
Growth Factors
; 30(2): 76-87, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22304408
14.
Parathyroid hormone-related protein in breast cancer bone metastasis.
Vitam Horm
; 120: 215-230, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35953110
15.
gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
J Bone Miner Res
; 37(2): 185-201, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34477239
16.
Sex-Specific Differences in Gsα-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone.
JBMR Plus
; 6(12): e10695, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36530190
17.
Multiple actions of parathyroid hormone-related protein in breast cancer bone metastasis.
Br J Pharmacol
; 178(9): 1923-1935, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31087800
18.
From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression.
Front Oncol
; 11: 644303, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33828987
19.
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.
J Bone Oncol
; 31: 100407, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34934614
20.
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.
JBMR Plus
; 5(4): e10465, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33869989